Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Ross

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 1, 1995
Clinical experience with acarbose: results of a Canadian multicentre studyN W Rodger, J L Chiasson, R G Josse, et al.
Diabetes Care|October 17, 1998
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrateT M Wolever, J L Chiasson, R G Josse, et al.
Annals of Internal Medicine|December 15, 1994
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trialJ L Chiasson, R G Josse, J A Hunt, et al.
Diabetes, Obesity & Metabolism|October 10, 2014
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trialS A Ross, A E Caballero, S Del Prato, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1995
One-year acarbose treatment raises fasting serum acetate in diabetic patientsT M Wolever, R Radmard, J L Chiasson, et al.
The American Journal of Clinical Nutrition|June 1, 1994
Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitusT M Wolever, P M Nguyen, J L Chiasson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouseS A Ross, J Y Wong, J J Clifford, et al.
British Journal of Pharmacology|July 1, 2008
Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig modelX Yao, D L Anderson, S A Ross, et al.
Journal of Medical Genetics|September 3, 2004
Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3N M Solomon, S A Ross, T Morgan, et al.
Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 1, 1995
Clinical experience with acarbose: results of a Canadian multicentre studyN W Rodger, J L Chiasson, R G Josse, et al.
Diabetes Care|October 17, 1998
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrateT M Wolever, J L Chiasson, R G Josse, et al.
Annals of Internal Medicine|December 15, 1994
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trialJ L Chiasson, R G Josse, J A Hunt, et al.
Diabetes, Obesity & Metabolism|October 10, 2014
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trialS A Ross, A E Caballero, S Del Prato, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1995
One-year acarbose treatment raises fasting serum acetate in diabetic patientsT M Wolever, R Radmard, J L Chiasson, et al.
The American Journal of Clinical Nutrition|June 1, 1994
Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitusT M Wolever, P M Nguyen, J L Chiasson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouseS A Ross, J Y Wong, J J Clifford, et al.
British Journal of Pharmacology|July 1, 2008
Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig modelX Yao, D L Anderson, S A Ross, et al.
Journal of Medical Genetics|September 3, 2004
Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3N M Solomon, S A Ross, T Morgan, et al.
Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.
Pageof 17